Clinical Evaluation of Intuitive, Bidirectional Strategies for the Control of Multi-articulated Prostheses for Upper Limb Amputation

April 2, 2025 updated by: Christian Cipriani, Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
The investigators propose to validate a non-invasive upper limb prosthesis capable of combining: 1) intuitive movement control through machine learning applied to myoelectric signals, and 2) vibrotactile sensory feedback in response to touch and object release events. The prosthesis is composed at the minimum of skin-surface electrodes for myoelectric signals, vibrotactile actuators, a multi-articulated and instrumented hand prosthesis and a centralized control system. Such system is validated for several weeks in non-supervised environments.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The investigators propose a pilot single-center study, randomized with crossover design to compare the intuitive control strategy with the standard-in-care direct control strategy.

Primary Objectives The primary objective is to validate a non-invasive, transradial prosthesis that integrates the latest advancements for intuitive, bidirectional and multi-articulated control. This validation is intended to be conducted in unsupervised environments (i.e., home-use). The prosthesis under validation combines intuitive movement control through pattern recognition applied to myoelectric signals, and vibrotactile sensory feedback in response to touch and object release events.

The validation is conducted through well-established functional tests in the field designed to measure dexterity and motor coordination, and through data on daily usage.

Secondary Objectives The secondary objective is to validate the proposed prosthesis based on subjective assessments regarding user satisfaction, perceived capacity to control the device, and perceived level of disability.

Additionally, the study aims to assess whether participation in this research has any impact on the control of the clinically used prosthesis. To this end, both functional tests and self-assessment questionnaires will be used to evaluate the clinical prosthesis before and after the trial protocol.

Study Type

Interventional

Enrollment (Estimated)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Bo
      • Bologna, Bo, Italy, 40136
        • Recruiting
        • IRCCS Istituto Ortopedico Rizzoli
        • Contact:
          • Paolo Sassu, Medical Doctor, Surgeon, PhD
          • Phone Number: 0039 051 636 6111
          • Email: paolo.sassu@ior.it
        • Contact:
          • Paolo Sassu, Medical Director, Clinic IV

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • subjects with transradial amputation, and minimum experience in the use of myoelectric prosthesis;
  • subjects who have expressed informed consent to participate in the study and consent to data processing.

Exclusion Criteria:

  • subjects with obvious visual and oculomotor defects;
  • concomitant comorbidities/disabilities/chronic conditions, general or localized (Multiple Sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.), which may interfere with the performance of the study;
  • pregnancy or breastfeeding;
  • declared or evident cognitive deficits that compromise the understanding of the required tasks (mini Mental State Examination≤ 24);
  • difficulty in understanding the Italian language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: machine learning based prosthesis control
A non-invasive upper limb prosthesis whose control is facilitated through machine learning applied to myoelectric signals. The movements on the prosthesis are triggered by intuitive muscular contractions performed at the residual limb.
The intervention includes an upper limb prosthesis composed at the minimum by skin-surface electrodes for myoelectric signals, a vibrotactile actuator, a multi-articulated and instrumented hand prosthesis and a centralized control system. The centralized prosthetic controller processes the myoelectric signals acquired at the residual limb to enable the movements on the multi-articulated prosthesis.
Active Comparator: conventional direct control
A non-invasive upper limb prosthesis whose control is enable by standard-in-care movement control strategy. The movements on the prosthesis are sequentially triggered through simple thresholds applied to myoelectric signals.
The intervention includes an upper limb prosthesis composed at the minimum by skin-surface electrodes for myoelectric signals, a vibrotactile actuator, a multi-articulated and instrumented hand prosthesis and a centralized control system. The centralized prosthetic controller processes the myoelectric signals acquired at the residual limb to enable the movements on the multi-articulated prosthesis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Southampton Hand Assessment Procedure (SHAP)
Time Frame: Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
The test consists of sequentially manipulating 6 lightweight and 6 heavyweight abstract objects and 14 activities of daily living over a specific formboard. Lightweight objects should be manipulated first. The task involves pushing a button to start a timer, picking up and moving the object from the rear slot to the front slot on the board, and completing the task by depressing the button on the timer again.
Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
Clothespin Relocation Test (CRT)
Time Frame: Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
The objective is to evaluate the performance of a prosthetic user in a controlled environment and subsequently provide a measure of the user's expected functionality level outside the laboratory/clinic. The user is instructed to allocate three clothespins between a horizontal rod and a vertical rod and asked to fill out a post-test survey after five trials of the CRT.
Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
Pick and Lift Test (PLT)
Time Frame: Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
The PLT measures motor coordination, i.e., the ability to coordinate the grip force and the load force while lifting an object, as well as the reliability of the recorded control signal while transporting the object. While the subject is sitting on a chair with the intact arm parallel to the trunk, and the amputated limb extending anteriorly on a table, he/she is asked to lift a small object from the table with the prosthesis.
Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
Virtual Egg Test (VET)
Time Frame: Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
The VET resembles the task of transporting fragile and robust objects, thus requiring both gross and fine dexterity. The test is composed of 11 Virtual Eggs that collapse if the grasping force exceeds their breaking thresholds, ranging from 0.4 N to 11.5 N. The test aims to transport each Virtual Egg over the barrier in the centre of the test platform without breaking it and as fast as possible. The metrics measured during the test are combined and provide two indexes that evaluate, respectively, gross and fine dexterity.
Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again after at least 1 wash-out week from the last home-trial
Usage of the prosthesis
Time Frame: Usage data will be recorded by the prosthesis during the two 4 weeks home-trials
The prosthesis, for as long as it is powered, will log real-time information about its usage during the day. Such data will allow us to calculate the total wear/use time, as well as the quality of the usage (which moments are used and how often). The data should also provide basic information for debugging in case of system failures and adverse events.
Usage data will be recorded by the prosthesis during the two 4 weeks home-trials

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NASA-TLX questionnaire
Time Frame: Administered after each functional test (primary outcomes). Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again at the end of the study
The NASA-TLX is a questionnaire to assess subjective workload, in terms of mental, physical, temporal, performance, effort and frustration. The resulting score ranges from 0 to 100, where 0 means no workload (very easy) and 100 means maximum workload (extremely demanding).
Administered after each functional test (primary outcomes). Measured at the baseline with the clinical prosthesis already in use (if any), then measured at the first and last week of each home-trial. Lastly, measured again at the end of the study
abilHAND-ULA
Time Frame: Administered before, after and at each week of the two home-trials
The abilHAND-ULA is a questionnaire for self-assessing the perceived manual ability for individuals with upper limb amputation. The cumulative score ranges from 0 to 66, with higher scores indicating better manual ability.
Administered before, after and at each week of the two home-trials
OPUS-UEFS
Time Frame: Administered before, after and at each week of the two home-trials
The Orthotics and Prosthetics User's Survey - Upper Extremity Functional Scale for Prosthesis Users (OPUS-UEFS) is a self-report measure designed to assess the functional status of individuals using upper limb prostheses, considering the level of amputation and prosthesis type. Each of the 23 items is rated on a 5-point scale (0 = cannot do this activity, 5 = very easy). The cumulative score ranges from 0 to 92, with higher scores indicating greater functional ability.
Administered before, after and at each week of the two home-trials
TAPES
Time Frame: Administered before, after and at each week of the two home-trials
The Trinity Amputation and Prosthesis Experience Scales (TAPES) is a self-administered questionnaire that comprises psychosocial adjustment, activity restriction, and prosthetic satisfaction domains, each with 3 subscales. Each subscale is scored individually, with higher scores consistently indicating more positive outcomes. Summing scores across different subscales is not appropriate.
Administered before, after and at each week of the two home-trials
QuickDASH
Time Frame: Administered before, after and at each week of the two home-trials
The Disability of the Arm, Shoulder and Hand is a self-administered questionnaire aimed at evaluating upper limb function. It is a 30-item questionnaire (main section) where each item is rated from 1 to 5 for increased difficulty/severity. The overall score ranges from 0 to 100.
Administered before, after and at each week of the two home-trials
SUS
Time Frame: Administered before, after and at each week of the two home-trials
The System Usability Scale (SUS) is a ten-item attitude Likert scale giving a global view of subjective assessment of usability. Users respond to 10 statements, rating them from 1 (Strongly Disagree) to 5 (Strongly Agree). The higher the score, the higher the perceived usability. Usually a score of 68 is the average industrial benchmark, and a score >80 is considered as excellent.
Administered before, after and at each week of the two home-trials

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

March 10, 2025

First Submitted That Met QC Criteria

March 14, 2025

First Posted (Actual)

March 20, 2025

Study Record Updates

Last Update Posted (Actual)

April 3, 2025

Last Update Submitted That Met QC Criteria

April 2, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe